Attached files

file filename
10-Q - 10-Q - WEST PHARMACEUTICAL SERVICES INCwst-20200331.htm
EX-32.2 - EX-32.2 - WEST PHARMACEUTICAL SERVICES INCex322q12020.htm
EX-31.2 - EX-31.2 - WEST PHARMACEUTICAL SERVICES INCex312q12020.htm
EX-31.1 - EX-31.1 - WEST PHARMACEUTICAL SERVICES INCex311q12020.htm

EXHIBIT 32.1


CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO SECTION 906 OF
THE SARBANES-OXLEY ACT OF 2002


In connection with the Quarterly Report on Form 10-Q of West Pharmaceutical Services, Inc. (the “Company”) for the period ended March 31, 2020, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Eric M. Green, President and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



/s/ Eric M. Green
Eric M. Green
President and Chief Executive Officer

Date: April 24, 2020